Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma

Area of Science:

• Hematology
• Biophysics
• Oncology

Background:

• Clot retraction is crucial for hemostasis and is often impaired in multiple myeloma.
• Previous studies suggested platelet dysfunction as the cause of decreased clot retraction in myeloma.

Purpose of the Study:

• To investigate the underlying mechanisms of impaired clot retraction in immunoglobulin (Ig) G multiple myeloma.
• To quantitatively assess fibrin structure and platelet-fibrin interactions in myeloma patients.

Main Methods:

• Utilized a novel instrument for simultaneous measurement of platelet force and clot elastic modulus.
• Calculated fibrin fiber mass-to-length ratios using gel turbidity.
• Assessed platelet force development and clot elastic moduli in platelet-rich plasma gels from 10 IgG myeloma patients and healthy controls.

Main Results:

• Myeloma patients exhibited significantly smaller fibrin fiber mass-to-length ratios (0.98 x 10^13 Da/cm) compared to controls (1.36 x 10^13 Da/cm), indicating thinner fibers.
• Myeloma clots showed markedly increased elastic moduli (51,013 dyn/cm^2) versus controls (23,355 dyn/cm^2), signifying reduced flexibility.
• Platelet force development at 1,200 seconds was comparable between myeloma patients (8,315 dyn) and controls (6,906 dyn).

Conclusions:

• Abnormal clot retraction in multiple myeloma is primarily attributed to alterations in fibrin clot structure.
• Platelet function is likely not the main contributor to impaired clot retraction in IgG myeloma.
• Findings highlight the role of fibrin network abnormalities in the hemostatic defects associated with multiple myeloma.